| Description |
1 online resource (xii, 236 pages) |
| Contents |
ADVANCES IN MEDICINE AND BIOLOGY: VOLUME 103; ADVANCES IN MEDICINE AND BIOLOGY: VOLUME 103; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: THE EFFECT OF CARNITINE SUPPLEMENTATION ON HEPATIC ENCEPHALOPATHY (HE) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH); ABSTRACT; 1. INTRODUCTION; 2. HEPATIC ENCEPHALOPATHY (HE); 2.1. The Pathogenesis of HE; 2.2. The Diagnosis of HE; 2.3. The Treatment of HE; 2.3.1. Overview; 2.3.2. L-Carnitine Supplementation for HE; 3. NASH; 3.1. The Pathogenesis of NASH; 3.2. The Treatment of NASH; 3.3. L-Carnitine Supplementation for NASH |
|
CONCLUSIONREFERENCES; BIOGRAPHICAL SKETCH; Chapter 2: THE ROLE OF ACYL/FREE CARNITINE RATIO ON UREMIC CARDIOMYOPATHY IN CHRONIC HEMODIALYSIS PATIENTS; ABSTRACT; INTRODUCTION; METHODS; Subjects; Echocardiographic Examination; Statistical Analysis; RESULTS; DISCUSSION; CONFLICT OF INTEREST; CONCLUSION; REFERENCES; BIOGRAPHICAL SKETCH; Chapter 3: FERMENTED MILK WITH LACTIC ACID BACTERIA ENRICHED OF ANGIOTENSIN-I CONVERTING ENZYME (ACE)-INHIBITORY PEPTIDES; ABSTRACT; 1. INTRODUCTION; 2. HYPERTENSION; 3. ANGIOTENSIN-I CONVERTING ENZYME (ACE); 4. ACE INHIBITORS; 5. FUNCTIONAL FOOD |
|
6. BIOACTIVE PEPTIDES IN FOOD PROTEINS7. PROTEOLYSIS OF MILK PROTEIN; 8. RELEASE OF ACE INHIBITORY PEPTIDESIN FERMENTED MILK; 9. ACE-INHIBITORY AND ANTIHYPERTENSIVEACTIVITY ASSAYS; CONCLUSION; REFERENCES; Chapter 4: BLACK TEA IN MILK AS A CARRIER AND SOURCE FOR POTENTIAL ANTIOXIDANT COMPOUNDS; ABSTRACT; 1. INTRODUCTION; 2. BLACK TEA; 3. COMPOSITION OF BLACK TEA; 4. POTENT SOURCE OF ANTIOXIDANT IN BLACK TEA; 5. THE ANTIOXIDANT POTENTIAL OFBLACK TEA WITH MILK; CONCLUSION; REFERENCES; Chapter 5: HOW TO DEAL WITH AORTIC VALVE STENOSIS IN PATIENTS AT INTERMEDIATEHIGH RISK IN THE MODERN ERA |
|
ABSTRACT1. INTRODUCTION; 2. EPIDEMIOLOGY AND RISK CALCULATOR; 3. LITERATURE RESULTS; 4. INDICATIONS AND DEVICES FOR AVR; 5. DISCUSSION; REFERENCES; Chapter 6: DERMATOPHYTE INFECTIONS: CLINICAL SIGNS, DIAGNOSIS AND TOPICAL THERAPY; ABSTRACT; INTRODUCTION; EPIDEMIOLOGY; CLINICAL SIGNS; TINEA CAPITIS; TINEA CORPORIS; TINEA CRURIS; TINEA PEDIS; TINEA MANUUM; TINEA UNGUIUM; DIAGNOSIS; DIRECT EXAMINATION; CULTURE; HISTOPATHOLOGICAL EXAMINATION; MOLECULAR DETECTION; TOPICAL THERAPY; TOPICAL TREATMENT OF TINEA CAPITIS; TOPICAL TREATMENT OF TINEA INFECTION OF THE SKIN |
|
TOPICAL TREATMENT OF TINEA UNGUIUMREFERENCES; Chapter 7: HUMAN CRYPTOSPORIDIOSIS: SPECIES, SUBTYPES, DIFFERENCES IN PATHOGENY AND CLINICAL MANIFESTATIONS, AND MATHEMATICAL METHODS FOR DNA SEQUENCE ANALYSIS; ABSTRACT; 1. INTRODUCTION; 2. PATHOGENY AND CLINICAL FEATURES INHUMAN CRYPTOSPORIDIOSIS; 2.1. Methodology; 2.1.1. Study Population and Enrollment; 2.1.2. Stool Samples Collection and Routine; Parasitological Investigations; 2 1.3. DNA Extraction, Genotyping and Subtyping; 2.1.4. Statistical Analysis; 2.2. Findings |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record |
| Subject |
Internal medicine.
|
|
Internal Medicine
|
|
HEALTH & FITNESS / Diseases / General
|
|
MEDICAL / Clinical Medicine
|
|
MEDICAL / Diseases
|
|
MEDICAL / Evidence-Based Medicine
|
|
MEDICAL / Internal Medicine
|
|
Internal medicine
|
| Form |
Electronic book
|
| Author |
Berhardt, Leon V., editor.
|
| ISBN |
9781634856621 |
|
1634856627 |
|
